Carcinoembryonic antigen(CEA) is a biomarker used for monitoring CRC recurrence and is not a valid diagnostic biomarker from a clinical standpoint for its low sensitivity and specificity. This evidence concerns the gene CEACAM5 and colorectal carcinoma.